cephalosporin c has been researched along with Esophageal and Gastric Varices in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraldes, JG; Albillos, A; Alvarado, E; Amitrano, L; Bañares, R; Bosch, J; Bureau, C; Calleja, JL; Cañete, N; Casas, M; Castellote, J; Catalina, MV; Conejo, I; Dell'Era, A; Ferlitsch, A; Fischer, P; García-Pagán, JC; Genescà, J; Giráldez, Á; Gluud, LL; Gronbaek, H; Guardascione, MA; Hernández-Gea, V; Hernández-Guerra, M; Ibañez-Samaniego, L; Jansen, C; Krag, A; Laleman, W; Llop, E; Martínez, J; Masnou, H; Mundi, JL; Nevens, F; Noronha-Ferreira, C; Palazon, JM; Perez-Campuzano, V; Primignani, M; Procopet, B; Robic, MA; Rodrigues, S; Rodríguez, M; Rodríguez-de-Santiago, E; Romero-Gomez, M; Rudler, M; Sassatelli, R; Schwarzer, R; Senzolo, M; Silva-Junior, G; Téllez, L; Thabut, D; Trebicka, J; Villanueva, C; Zipprich, A | 1 |
| Lee, YL; Lin, CF; Liu, YT | 1 |
| Fukui, H | 1 |
| Cho, YK; Jeon, WK; Kim, BI; Kim, DJ; Kim, HJ; Kim, HS; Park, DI; Park, JH; Sohn, CI | 1 |
| Choi, SK; Joo, YE; Jun, CH; Kim, HS; Kim, SJ; Kim, YD; Lee, WS; Park, CH; Rew, JS | 1 |
2 trial(s) available for cephalosporin c and Esophageal and Gastric Varices
| Article | Year |
|---|---|
Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Intestines; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Permeability; Predictive Value of Tests; Prospective Studies; Republic of Korea; Risk Assessment; Risk Factors; ROC Curve; Time Factors; Treatment Outcome | 2011 |
Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Cephalosporins; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Prospective Studies; Recurrence | 2006 |
3 other study(ies) available for cephalosporin c and Esophageal and Gastric Varices
| Article | Year |
|---|---|
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cephalosporins; Esophageal and Gastric Varices; Female; Hemorrhage; Humans; Incidence; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Quinolones; Risk Factors | 2021 |
Streptococcus sanguinis meningitis following endoscopic ligation for oesophageal variceal haemorrhage.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Male; Meningitis, Bacterial; Penicillin G; Streptococcal Infections; Streptococcus sanguis | 2013 |
How leaky gut and endotoxemia induce bacterial infection in cirrhosis and gastrointestinal hemorrhage?
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Endotoxemia; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Intestines; Liver Cirrhosis; Permeability; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2011 |